Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. save search
NeuroTrauma Sciences Announces Key Appointments to its Executive Leadership Team
Published: 2023-05-10 (Crawled : 12:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.49%
H: 0.13%
C: -0.96%
sciences
Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.1%
H: 0.52%
C: 0.36%
ARVN | $33.96 -2.69% -2.77% 530K
|
Health Technology
|
| O: 1.86%
H: 5.16%
C: -4.27%
arv-471 breast cancer medical
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.1%
H: 0.52%
C: 0.36%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
update financial results
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-05 (Crawled : 11:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.39%
H: 0.31%
C: 0.29%
ARVN | $33.96 -2.69% -2.77% 530K
|
Health Technology
|
| O: 2.04%
H: 5.9%
C: 5.46%
update financial results
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-04 (Crawled : 12:20) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.73%
H: 0.68%
C: 0.16%
INSM | $25.25 4.73% 4.51% 2.1M
|
Health Technology
|
| O: -1.11%
H: 3.47%
C: -0.1%
business update financial results
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published: 2023-05-03 (Crawled : 18:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.73%
H: 0.68%
C: 0.16%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.06%
H: 0.29%
C: -0.7%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.29%
H: 1.19%
C: 0.56%
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: -0.38%
H: 1.38%
C: 1.2%
LXRX | $1.62 -5.26% -5.56% 3.5M
|
Health Technology
|
| O: 2.19%
H: 13.21%
C: 10.0%
report reach global duchenne market
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 12:20) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.36%
H: 0.48%
C: -1.91%
DCPH | $14.67 0.62% 0.61% 430K
|
Health Technology
|
| O: -6.99%
H: 7.22%
C: 4.74%
pharmaceuticals financial results
GlycoEra AG Expands Board of Directors and Appoints Santiago Arroyo, MD to its Board of Directors as an independent board member
Published: 2023-05-02 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.45%
H: 0.69%
C: 0.42%
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
Published: 2023-05-02 (Crawled : 12:20) - mindmed.co
MNMD | $8.885 2.36% 2.31% 1.2M
|
n/a
|
| O: -1.04%
H: 0.79%
C: -1.06%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
ALC | $80.76 0.19% 0.0% 940K
|
Health Technology
|
| O: -0.69%
H: 0.77%
C: 0.11%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.28%
H: 0.32%
C: 0.11%
JAZZ | $109.685 0.79% 0.78% 380K
|
Health Technology
|
| O: -0.5%
H: 0.74%
C: -2.58%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -9.64%
H: 5.99%
C: 2.76%
FBRX 4 | $0.7318 1.64% 1.61% 4.6K
|
Health Technology
|
| O: -1.85%
H: 4.72%
C: 0.94%
momentum positive
Pfizer Reports First-Quarter 2023 Results
Published: 2023-05-02 (Crawled : 12:20) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
BHVN | News 0 d | $39.61 3.34% 0.0% 2.1M
|
Health Technology
|
| O: -0.52%
H: 0.44%
C: -2.29%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.84%
H: 2.03%
C: 0.01%
results
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
Published: 2023-03-31 (Crawled : 14:20) - globenewswire.com
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -2.05%
H: 11.75%
C: -2.1%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.42%
H: 0.69%
C: 0.62%
CLSD | News P | $1.36 -3.55% -3.68% 230K
|
Health Technology
|
| O: 2.4%
H: 7.14%
C: 6.12%
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: 1.07%
H: 0.94%
C: -1.65%
XTANDI® (enzalutamide) plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide
Published: 2023-04-29 (Crawled : 16:20) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
xtandi cancer risk plus
U.S. FDA Approves PREVNAR 20®, Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
Published: 2023-04-27 (Crawled : 22:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.03%
H: 0.54%
C: 0.31%
fda pneumococcal children vaccine
Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit
Published: 2023-04-26 (Crawled : 01:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.43%
H: 0.08%
C: -1.35%
pharma business
Stomach Cancer Treatment Market Report 2023: Growing Demand for Painless Low-Cost Treatment and Favorable Reimbursement Scenarios Bolsters Sector
Published: 2023-04-14 (Crawled : 02:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.08%
H: 0.49%
C: -0.76%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.24%
H: 0.55%
C: 0.13%
report favorable cancer treatment growing market
Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders on April 27
Published: 2023-04-13 (Crawled : 16:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.39%
H: 0.41%
C: -0.14%
meeting
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech
Published: 2023-04-04 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 0.05%
H: 0.89%
C: -2.88%
ABUS | $2.74 3.79% 3.65% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: -2.29%
patent biopharma sciences
FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
Published: 2023-04-04 (Crawled : 11:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
fda drug
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer
Published: 2023-04-04 (Crawled : 03:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
australia group acquisition
Researchers Show Lorlatinib is Safe and Effective for Patients with ALK-Driven Relapsed/Refractory High-Risk Neuroblastoma
Published: 2023-04-03 (Crawled : 18:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.27%
H: 1.91%
C: 1.62%
show
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.